BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10384116)

  • 21. Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor.
    Izquierdo M; Grandien A; Criado LM; Robles S; Leonardo E; Albar JP; de Buitrago GG; Martínez-A C
    EMBO J; 1999 Jan; 18(1):156-66. PubMed ID: 9878059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of apoptosis in thymocytes.
    Cairns JS; Mainwaring MS; Cacchione RN; Walker JA; McCarthy SA
    Thymus; 1993 May; 21(3):177-93. PubMed ID: 8236376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation of FLIP, RIP and Bcl-x(L) in Fas-mediated T-cell death.
    Djerbi M; Malinowski MM; Yagita H; Zhivotovsky B; Grandien A
    Scand J Immunol; 2007 Oct; 66(4):410-21. PubMed ID: 17850585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymus-derived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCR-mediated thymocyte activation.
    Vacchio MS; Lee JY; Ashwell JD
    J Immunol; 1999 Aug; 163(3):1327-33. PubMed ID: 10415031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.
    Keir ME; Latchman YE; Freeman GJ; Sharpe AH
    J Immunol; 2005 Dec; 175(11):7372-9. PubMed ID: 16301644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bax alpha perturbs T cell development and affects cell cycle entry of T cells.
    Brady HJ; Gil-Gómez G; Kirberg J; Berns AJ
    EMBO J; 1996 Dec; 15(24):6991-7001. PubMed ID: 9003775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired negative selection in CD28-deficient mice.
    Noel PJ; Alegre ML; Reiner SL; Thompson CB
    Cell Immunol; 1998 Aug; 187(2):131-8. PubMed ID: 9732701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential roles for Bim and Nur77 in thymocyte clonal deletion induced by ubiquitous self-antigen.
    Hu QN; Baldwin TA
    J Immunol; 2015 Mar; 194(6):2643-53. PubMed ID: 25687757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes.
    Bouillet P; Purton JF; Godfrey DI; Zhang LC; Coultas L; Puthalakath H; Pellegrini M; Cory S; Adams JM; Strasser A
    Nature; 2002 Feb; 415(6874):922-6. PubMed ID: 11859372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes.
    Hara H; Takeda A; Takeuchi M; Wakeham AC; Itié A; Sasaki M; Mak TW; Yoshimura A; Nomoto K; Yoshida H
    J Immunol; 2002 Mar; 168(5):2288-95. PubMed ID: 11859117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a putative G protein-coupled receptor induced during activation-induced apoptosis of T cells.
    Choi JW; Lee SY; Choi Y
    Cell Immunol; 1996 Feb; 168(1):78-84. PubMed ID: 8599842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The T cell receptor repertoire of CD4-8+ thymocytes is altered by overexpression of the BCL-2 protooncogene in the thymus.
    Tao W; Teh SJ; Melhado I; Jirik F; Korsmeyer SJ; Teh HS
    J Exp Med; 1994 Jan; 179(1):145-53. PubMed ID: 8270861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspase 3 is not essential for the induction of anergy or multiple pathways of CD8+ T-cell death.
    Murakami K; Liadis N; Sarmiento J; Elford AR; Woo M; Nguyen LT; Mak TW; Ohashi PS
    Eur J Immunol; 2010 Dec; 40(12):3372-7. PubMed ID: 21110320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus.
    Alam A; Braun MY; Hartgers F; Lesage S; Cohen L; Hugo P; Denis F; Sékaly RP
    J Exp Med; 1997 Nov; 186(9):1503-12. PubMed ID: 9348308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD30 (Ber-H2) expression by thymocytes and thymic epithelial cells during the late first and second trimester of gestation: an immunohistochemical and in situ hybridization (ISH) study.
    Lambropoulou M; Tamiolakis D; Venizelos I; Nikolaidou S; Bolioti S; Limberis V; Galazios G; Tsikouras P; Koutsougeras G; Karamanidis D; Papadopoulos N
    Med Sci Monit; 2007 Dec; 13(12):BR280-5. PubMed ID: 18049429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune-associated nucleotide-1 (IAN-1) is a thymic selection marker and defines a novel gene family conserved in plants.
    Poirier GM; Anderson G; Huvar A; Wagaman PC; Shuttleworth J; Jenkinson E; Jackson MR; Peterson PA; Erlander MG
    J Immunol; 1999 Nov; 163(9):4960-9. PubMed ID: 10528200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing and casting for actors of thymic negative selection.
    Dautigny N; Le Campion A; Lucas B
    J Immunol; 1999 Feb; 162(3):1294-302. PubMed ID: 9973382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer.
    Jiang H; Granville DJ; McManus BM; Levy JG; Hunt DW
    Clin Immunol; 1999 May; 91(2):178-87. PubMed ID: 10227810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspase enzyme activity is not essential for apoptosis during thymocyte development.
    Doerfler P; Forbush KA; Perlmutter RM
    J Immunol; 2000 Apr; 164(8):4071-9. PubMed ID: 10754300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Cdk2 is a requirement for antigen-mediated thymic negative selection.
    Williams O; Gil-Gómez G; Norton T; Kioussis D; Brady HJ
    Eur J Immunol; 2000 Feb; 30(2):709-13. PubMed ID: 10671231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.